Perrigo Company plc Share Price TEL AVIV STOCK EXCHANGE

Equities

PRGO

IE00BGH1M568

Pharmaceuticals

Delayed TEL AVIV STOCK EXCHANGE 5-day change 1st Jan Change
- ILa -.--% Intraday chart for Perrigo Company plc -2.55% -3.73%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 462.31Cr 1,69500Cr 39TCr Sales 2025 * 483.28Cr 1,77200Cr 40TCr Capitalization 412.91Cr 1,51400Cr 34TCr
Net income 2024 * -7.4Cr -2.71TCr -617.12Cr Net income 2025 * 11Cr 3.89TCr 883.98Cr EV / Sales 2024 * 1.59 x
Net Debt 2024 * 320.86Cr 1,17700Cr 27TCr Net Debt 2025 * 301.2Cr 1,10500Cr 25TCr EV / Sales 2025 * 1.48 x
P/E ratio 2024 *
-20.9 x
P/E ratio 2025 *
189 x
Employees -
Yield 2024 *
3.64%
Yield 2025 *
3.87%
Free-Float 99.69%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 55 30/23/30
Director of Finance/CFO 49 16/22/16
Chief Tech/Sci/R&D Officer - 01/15/01
Members of the board TitleAgeSince
Chairman 55 15/20/15
Director/Board Member 68 06/17/06
Director/Board Member 67 06/17/06
More insiders
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.29 USD
Average target price
39.5 USD
Spread / Average Target
+30.41%
Consensus
1st Jan change Capi.
+31.37% 59TCr
-2.60% 36TCr
+20.83% 33TCr
+5.69% 29TCr
+14.83% 24TCr
+9.93% 21TCr
-6.95% 20TCr
+10.77% 17TCr
+0.10% 16TCr
Other Pharmaceuticals
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW